SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'IBP'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1CQE_A_FLPA1650_1 (PROTEIN (PROSTAGLANDIN H2 SYNTHASE-1))	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.41A	1cqeA-4ph9A: 59.1	1cqeA-4ph9A: 63.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1CQE_B_FLPB2650_1 (PROTEIN (PROSTAGLANDIN H2 SYNTHASE-1))	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.42A	1cqeB-4ph9A: 59.2	1cqeB-4ph9A: 63.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1EQG_A_IBPA701_1 (PROSTAGLANDIN H2 SYNTHASE-1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	8 / 9	VAL A 117 ARG A 121 VAL A 350 TYR A 356 LEU A 360 ALA A 528 SER A 531 LEU A 532	BOG A 604 (-3.9A) BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.55A	1eqgA-4ph9A: 59.2	1eqgA-4ph9A: 63.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1EQG_B_IBPB1701_1 (PROSTAGLANDIN H2 SYNTHASE-1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 11	VAL A 117 ARG A 121 VAL A 350 SER A 354 TYR A 356 LEU A 360 TYR A 386 ALA A 528 SER A 531 LEU A 532	BOG A 604 (-3.9A) BOG A 604 ( 3.7A) IBP A 601 (-4.3A) None IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.50A	1eqgB-4ph9A: 59.3	1eqgB-4ph9A: 63.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1EQH_A_FLPA701_1 (PROSTAGLANDIN H2 SYNTHASE-1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	VAL A 117 ARG A 121 VAL A 350 TYR A 356 LEU A 360 TYR A 386 TRP A 388 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 (-3.9A) BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.28A	1eqhA-4ph9A: 59.5	1eqhA-4ph9A: 63.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1EQH_B_FLPB1701_1 (PROSTAGLANDIN H2 SYNTHASE-1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	VAL A 117 ARG A 121 VAL A 350 TYR A 356 LEU A 360 TYR A 386 TRP A 388 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 (-3.9A) BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.32A	1eqhB-4ph9A: 59.5	1eqhB-4ph9A: 63.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FE2_A_LAXA700_1 (PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 10	VAL A 117 ARG A 121 PHE A 206 VAL A 229 VAL A 345 TYR A 349 VAL A 350 ASN A 376 LEU A 532	BOG A 604 (-3.9A) BOG A 604 ( 3.7A) None None None None IBP A 601 (-4.3A) EDO A 616 (-4.4A) IBP A 601 ( 4.9A)	0.41A	1fe2A-4ph9A: 58.4	1fe2A-4ph9A: 63.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FE2_A_LAXA700_2 (PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	6 / 12	PHE A 206 TYR A 386 TRP A 388 GLY A 527 ALA A 528 SER A 531	None IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	1.29A	1fe2A-4ph9A: 58.4	1fe2A-4ph9A: 63.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FE2_A_LAXA700_2 (PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	PHE A 210 LEU A 353 PHE A 382 TYR A 386 TRP A 388 PHE A 519 GLY A 527 ALA A 528 SER A 531 GLY A 534 LEU A 535	EDO A 616 (-3.5A) IBP A 601 ( 4.7A) None IBP A 601 (-4.8A) None None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) EDO A 616 (-3.0A) EDO A 616 ( 4.4A)	0.64A	1fe2A-4ph9A: 58.4	1fe2A-4ph9A: 63.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FE2_A_LAXA700_2 (PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	PHE A 210 LEU A 353 TYR A 356 PHE A 382 TYR A 386 TRP A 388 GLY A 527 ALA A 528 SER A 531 GLY A 534 LEU A 535	EDO A 616 (-3.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) None IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) EDO A 616 (-3.0A) EDO A 616 ( 4.4A)	0.37A	1fe2A-4ph9A: 58.4	1fe2A-4ph9A: 63.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1IGX_A_EPAA700_1 (PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	PHE A 206 PHE A 210 LEU A 353 TYR A 356 PHE A 382 TYR A 386 TRP A 388 GLY A 527 ALA A 528 SER A 531 GLY A 534 LEU A 535	None EDO A 616 (-3.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) None IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) EDO A 616 (-3.0A) EDO A 616 ( 4.4A)	0.53A	1igxA-4ph9A: 58.1	1igxA-4ph9A: 63.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1IGX_A_EPAA700_1 (PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	6 / 12	PHE A 211 LEU A 353 TYR A 356 PHE A 382 ALA A 528 SER A 531	HEM A 602 (-4.6A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) None IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	1.50A	1igxA-4ph9A: 58.1	1igxA-4ph9A: 63.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1PTH_A_SALA710_1 (PROSTAGLANDIN H2 SYNTHASE-1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	7 / 7	VAL A 117 ARG A 121 VAL A 350 LEU A 353 TYR A 356 ALA A 528 LEU A 532	BOG A 604 (-3.9A) BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.53A	1pthA-4ph9A: 58.7	1pthA-4ph9A: 63.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1PTH_B_SALB711_1 (PROSTAGLANDIN H2 SYNTHASE-1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	7 / 7	VAL A 117 ARG A 121 VAL A 350 LEU A 353 TYR A 356 ALA A 528 LEU A 532	BOG A 604 (-3.9A) BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.53A	1pthB-4ph9A: 58.7	1pthB-4ph9A: 63.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1PXX_A_DIFA701_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 10	VAL A 350 LEU A 353 LEU A 385 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.53A	1pxxA-4ph9A: 63.3	1pxxA-4ph9A: 96.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1PXX_B_DIFB1701_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 9	VAL A 350 LEU A 353 LEU A 385 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	0.51A	1pxxB-4ph9A: 63.3	1pxxB-4ph9A: 96.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1PXX_C_DIFC2701_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 LEU A 385 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) None IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.51A	1pxxC-4ph9A: 63.4	1pxxC-4ph9A: 96.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1PXX_D_DIFD3701_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 10	VAL A 350 LEU A 353 TYR A 356 LEU A 385 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) None IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	0.48A	1pxxD-4ph9A: 63.3	1pxxD-4ph9A: 96.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A58_D_RBFD303_1 (6,7-DIMETHYL-8-RIBIT YLLUMAZINE SYNTHASE)	2wd9	ACYL-COENZYME A SYNTHETASE ACSM2A, MITOCHONDRIAL (Homo sapiens)	5 / 11	ILE A 412 TRP A 442 GLY A 362 LEU A 270 HIS A 233	None None IBP A1570 (-3.9A) None None	1.45A	2a58C-2wd9A: 3.1 2a58D-2wd9A: 2.3	2a58C-2wd9A: 14.24 2a58D-2wd9A: 14.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2AYL_A_FLPA1701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.64A	2aylA-4ph9A: 59.3	2aylA-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2AYL_A_FLPA1701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 GLY A 527 ALA A 528 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.45A	2aylA-4ph9A: 59.3	2aylA-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2AYL_A_FLPA1701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	VAL A 350 LEU A 353 LEU A 360 TYR A 386 TRP A 388 PHE A 519 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None None IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.88A	2aylA-4ph9A: 59.3	2aylA-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2AYL_A_FLPA1701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	VAL A 350 LEU A 353 LEU A 360 TYR A 386 TRP A 388 PHE A 519 GLY A 527 ALA A 528 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.74A	2aylA-4ph9A: 59.3	2aylA-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2AYL_B_FLPB2701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.57A	2aylB-4ph9A: 59.4	2aylB-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2AYL_B_FLPB2701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 GLY A 527 ALA A 528 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.32A	2aylB-4ph9A: 59.4	2aylB-4ph9A: 64.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QD5_B_CHDB1103_0 (FERROCHELATASE)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	4 / 8	LEU A 360 SER A 120 VAL A 524 GLY A 527	IBP A 601 ( 4.7A) BOG A 604 (-2.8A) IBP A 601 ( 4.0A) IBP A 601 (-3.9A)	1.04A	2qd5B-4ph9A: undetectable	2qd5B-4ph9A: 21.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HS6_A_EPAA1_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	VAL A 117 VAL A 350 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 LEU A 535	BOG A 604 (-3.9A) IBP A 601 (-4.3A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) EDO A 616 ( 4.4A)	0.37A	3hs6A-4ph9A: 63.3	3hs6A-4ph9A: 99.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HS6_A_EPAA1_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	VAL A 117 VAL A 350 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531	BOG A 604 (-3.9A) IBP A 601 (-4.3A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	0.62A	3hs6A-4ph9A: 63.3	3hs6A-4ph9A: 99.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HS6_B_EPAB1_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	PHE A 210 GLY A 228 TYR A 356 ASN A 376 ILE A 378 PHE A 382 ALA A 528 SER A 531 GLY A 534	EDO A 616 (-3.5A) EDO A 616 ( 4.5A) IBP A 601 (-4.5A) EDO A 616 (-4.4A) None None IBP A 601 (-3.4A) IBP A 601 ( 3.3A) EDO A 616 (-3.0A)	0.72A	3hs6B-4ph9A: 63.6	3hs6B-4ph9A: 99.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HS6_B_EPAB1_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	PHE A 210 GLY A 228 TYR A 356 ASN A 376 ILE A 378 PHE A 382 TYR A 386 GLY A 527 ALA A 528 GLY A 534 LEU A 535	EDO A 616 (-3.5A) EDO A 616 ( 4.5A) IBP A 601 (-4.5A) EDO A 616 (-4.4A) None None IBP A 601 (-4.8A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) EDO A 616 (-3.0A) EDO A 616 ( 4.4A)	0.38A	3hs6B-4ph9A: 63.6	3hs6B-4ph9A: 99.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HS6_B_EPAB1_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	6 / 12	PHE A 211 TYR A 356 ILE A 378 PHE A 382 ALA A 528 SER A 531	HEM A 602 (-4.6A) IBP A 601 (-4.5A) None None IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	1.29A	3hs6B-4ph9A: 63.6	3hs6B-4ph9A: 99.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HS6_B_EPAB1_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	6 / 12	PHE A 211 TYR A 356 ILE A 378 PHE A 382 GLY A 527 ALA A 528	HEM A 602 (-4.6A) IBP A 601 (-4.5A) None None IBP A 601 (-3.9A) IBP A 601 (-3.4A)	1.37A	3hs6B-4ph9A: 63.6	3hs6B-4ph9A: 99.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KK6_A_CELA701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	7 / 12	GLN A 193 VAL A 350 LEU A 353 TRP A 388 PHE A 519 GLY A 527 SER A 531	None IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None None IBP A 601 (-3.9A) IBP A 601 ( 3.3A)	0.93A	3kk6A-4ph9A: 57.1	3kk6A-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KK6_A_CELA701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	GLN A 193 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TRP A 388 GLY A 527 ALA A 528 SER A 531	None IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	0.71A	3kk6A-4ph9A: 57.1	3kk6A-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KK6_B_CELB1701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	7 / 12	GLN A 193 VAL A 350 LEU A 353 TRP A 388 PHE A 519 GLY A 527 SER A 531	None IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None None IBP A 601 (-3.9A) IBP A 601 ( 3.3A)	0.90A	3kk6B-4ph9A: 56.8	3kk6B-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3KK6_B_CELB1701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	HIS A 90 GLN A 193 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TRP A 388 GLY A 527 SER A 531	None None IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) None IBP A 601 (-3.9A) IBP A 601 ( 3.3A)	0.64A	3kk6B-4ph9A: 56.8	3kk6B-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LN1_A_CELA682_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	HIS A 90 GLN A 193 VAL A 350 TYR A 356 LEU A 360 TRP A 388 ALA A 517 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	None None IBP A 601 (-4.3A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.53A	3ln1A-4ph9A: 63.8	3ln1A-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LN1_B_CELB682_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	HIS A 90 GLN A 193 VAL A 350 TYR A 356 LEU A 360 TRP A 388 ALA A 517 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	None None IBP A 601 (-4.3A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.53A	3ln1B-4ph9A: 63.9	3ln1B-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LN1_C_CELC682_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	HIS A 90 VAL A 350 TYR A 356 LEU A 360 TYR A 386 TRP A 388 ALA A 517 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	None IBP A 601 (-4.3A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.52A	3ln1C-4ph9A: 63.8	3ln1C-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LN1_D_CELD682_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	HIS A 90 GLN A 193 VAL A 350 SER A 354 TYR A 356 LEU A 360 TRP A 388 ALA A 517 VAL A 524 GLY A 527 ALA A 528 LEU A 532	None None IBP A 601 (-4.3A) None IBP A 601 (-4.5A) IBP A 601 ( 4.7A) None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.32A	3ln1D-4ph9A: 63.8	3ln1D-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3N8W_A_FLPA701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	VAL A 117 ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 (-3.9A) BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.47A	3n8wA-4ph9A: 58.7	3n8wA-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3N8X_A_NIMA701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	HIS A 90 ARG A 121 LEU A 353 TYR A 356 TYR A 386 TRP A 388 GLY A 527 ALA A 528 SER A 531 LEU A 532	None BOG A 604 ( 3.7A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.62A	3n8xA-4ph9A: 11.5	3n8xA-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3N8X_A_NIMA701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	HIS A 90 LEU A 353 TYR A 356 TYR A 386 TRP A 388 PHE A 519 GLY A 527 SER A 531 LEU A 532	None IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 (-4.8A) None None IBP A 601 (-3.9A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.72A	3n8xA-4ph9A: 11.5	3n8xA-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3N8X_B_NIMB1701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	HIS A 90 ARG A 121 LEU A 353 TYR A 356 LEU A 360 TRP A 388 GLY A 527 ALA A 528 SER A 531 LEU A 532	None BOG A 604 ( 3.7A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.61A	3n8xB-4ph9A: 57.9	3n8xB-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3N8X_B_NIMB1701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	8 / 12	LEU A 353 TYR A 356 LEU A 360 TRP A 388 PHE A 519 GLY A 527 SER A 531 LEU A 532	IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) None None IBP A 601 (-3.9A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.73A	3n8xB-4ph9A: 57.9	3n8xB-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3N8X_B_NIMB1701_2 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	3 / 3	VAL A 117 VAL A 350 SER A 354	BOG A 604 (-3.9A) IBP A 601 (-4.3A) None	0.12A	3n8xB-4ph9A: 57.9	3n8xB-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3N8Y_A_DIFA701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 11	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.80A	3n8yA-4ph9A: 34.1	3n8yA-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3N8Y_A_DIFA701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 11	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 GLY A 527 ALA A 528 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.61A	3n8yA-4ph9A: 34.1	3n8yA-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3N8Y_B_DIFB585_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	VAL A 345 VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 GLY A 527 ALA A 528 LEU A 532 LEU A 535	None IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A) EDO A 616 ( 4.4A)	0.47A	3n8yB-4ph9A: 32.9	3n8yB-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3N8Y_B_SALB900_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	4 / 5	VAL A 350 LEU A 353 TYR A 356 ALA A 528	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 (-3.4A)	0.45A	3n8yB-4ph9A: 32.9	3n8yB-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3N8Z_A_FLPA701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	VAL A 117 ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 (-3.9A) BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.55A	3n8zA-4ph9A: 58.5	3n8zA-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3N8Z_B_FLPB1701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 385 TYR A 386 TRP A 388 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) None IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.57A	3n8zB-4ph9A: 58.6	3n8zB-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NT1_A_NPSA5_1 (PROSTAGLANDIN-ENDOPE ROXIDE SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	0.65A	3nt1A-4ph9A: 64.9	3nt1A-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NT1_A_NPSA5_1 (PROSTAGLANDIN-ENDOPE ROXIDE SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	ARG A 121 VAL A 350 TYR A 356 LEU A 360 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.46A	3nt1A-4ph9A: 64.9	3nt1A-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NT1_B_NPSB4_1 (PROSTAGLANDIN-ENDOPE ROXIDE SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	ARG A 121 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531	BOG A 604 ( 3.7A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	0.70A	3nt1B-4ph9A: 65.0	3nt1B-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NT1_B_NPSB4_1 (PROSTAGLANDIN-ENDOPE ROXIDE SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	ARG A 121 VAL A 350 TYR A 356 LEU A 360 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.46A	3nt1B-4ph9A: 65.0	3nt1B-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PGH_A_FLPA701_1 (CYCLOOXYGENASE-2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	VAL A 117 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 VAL A 524 ALA A 528 SER A 531 LEU A 532	BOG A 604 (-3.9A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.54A	3pghA-4ph9A: 63.3	3pghA-4ph9A: 99.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PGH_A_FLPA701_1 (CYCLOOXYGENASE-2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	VAL A 117 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 LEU A 532	BOG A 604 (-3.9A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.37A	3pghA-4ph9A: 63.3	3pghA-4ph9A: 99.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PGH_B_FLPB701_1 (CYCLOOXYGENASE-2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 11	ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 MET A 523 VAL A 524 GLY A 527 ALA A 528	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A)	0.42A	3pghB-4ph9A: 25.4	3pghB-4ph9A: 99.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PGH_C_FLPC701_1 (CYCLOOXYGENASE-2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	VAL A 117 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 (-3.9A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.52A	3pghC-4ph9A: 63.3	3pghC-4ph9A: 99.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PGH_D_FLPD701_1 (CYCLOOXYGENASE-2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.56A	3pghD-4ph9A: 63.3	3pghD-4ph9A: 99.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RR3_A_FLRA700_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	VAL A 117 ARG A 121 VAL A 350 TYR A 356 LEU A 360 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 (-3.9A) BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.43A	3rr3A-4ph9A: 63.6	3rr3A-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RR3_B_FLRB700_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	VAL A 117 ARG A 121 VAL A 350 TYR A 356 LEU A 360 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 (-3.9A) BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.44A	3rr3B-4ph9A: 63.6	3rr3B-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RR3_C_FLRC700_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	VAL A 117 ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531	BOG A 604 (-3.9A) BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	0.60A	3rr3C-4ph9A: 63.6	3rr3C-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RR3_D_FLRD700_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	VAL A 117 ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531	BOG A 604 (-3.9A) BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	0.60A	3rr3D-4ph9A: 63.6	3rr3D-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4COX_A_IMNA701_1 (CYCLOOXYGENASE-2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	ARG A 121 VAL A 350 SER A 354 TYR A 356 LEU A 385 VAL A 524 GLY A 527 ALA A 528 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) None IBP A 601 (-4.5A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.70A	4coxA-4ph9A: 62.8	4coxA-4ph9A: 99.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4COX_A_IMNA701_1 (CYCLOOXYGENASE-2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	ARG A 121 VAL A 350 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.59A	4coxA-4ph9A: 62.8	4coxA-4ph9A: 99.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4COX_A_IMNA701_1 (CYCLOOXYGENASE-2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	8 / 12	VAL A 350 SER A 354 TYR A 356 LEU A 526 GLY A 527 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) None IBP A 601 (-4.5A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	1.25A	4coxA-4ph9A: 62.8	4coxA-4ph9A: 99.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4COX_B_IMNB701_1 (CYCLOOXYGENASE-2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	ARG A 121 VAL A 350 SER A 354 TYR A 356 LEU A 385 VAL A 524 GLY A 527 ALA A 528 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) None IBP A 601 (-4.5A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.69A	4coxB-4ph9A: 62.6	4coxB-4ph9A: 99.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4COX_B_IMNB701_1 (CYCLOOXYGENASE-2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	ARG A 121 VAL A 350 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.58A	4coxB-4ph9A: 62.6	4coxB-4ph9A: 99.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4COX_B_IMNB701_1 (CYCLOOXYGENASE-2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	VAL A 350 SER A 354 TYR A 356 LEU A 526 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) None IBP A 601 (-4.5A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	1.26A	4coxB-4ph9A: 62.6	4coxB-4ph9A: 99.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4COX_C_IMNC701_1 (CYCLOOXYGENASE-2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	ARG A 121 VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.56A	4coxC-4ph9A: 62.6	4coxC-4ph9A: 99.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4COX_D_IMND701_1 (CYCLOOXYGENASE-2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	ARG A 121 VAL A 350 SER A 354 TYR A 356 LEU A 385 VAL A 524 GLY A 527 ALA A 528 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) None IBP A 601 (-4.5A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.70A	4coxD-4ph9A: 62.8	4coxD-4ph9A: 99.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4COX_D_IMND701_1 (CYCLOOXYGENASE-2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	ARG A 121 VAL A 350 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.59A	4coxD-4ph9A: 62.8	4coxD-4ph9A: 99.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4COX_D_IMND701_1 (CYCLOOXYGENASE-2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	VAL A 350 SER A 354 TYR A 356 LEU A 526 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) None IBP A 601 (-4.5A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	1.27A	4coxD-4ph9A: 62.8	4coxD-4ph9A: 99.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4E1G_A_LNLA701_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	PHE A 206 PHE A 210 TYR A 356 ASN A 376 ILE A 378 PHE A 382 TYR A 386 GLY A 527 ALA A 528 SER A 531 GLY A 534 LEU A 535	None EDO A 616 (-3.5A) IBP A 601 (-4.5A) EDO A 616 (-4.4A) None None IBP A 601 (-4.8A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) EDO A 616 (-3.0A) EDO A 616 ( 4.4A)	0.28A	4e1gA-4ph9A: 64.6	4e1gA-4ph9A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4E1G_A_LNLA701_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	7 / 12	PHE A 211 TYR A 356 ILE A 378 PHE A 382 GLY A 527 ALA A 528 SER A 531	HEM A 602 (-4.6A) IBP A 601 (-4.5A) None None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	1.31A	4e1gA-4ph9A: 64.6	4e1gA-4ph9A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4E1G_A_LNLA701_2 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	5 / 5	ARG A 121 VAL A 350 LEU A 353 SER A 354 MET A 523	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None None	0.20A	4e1gA-4ph9A: 64.6	4e1gA-4ph9A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4E1G_B_LNLB701_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	ARG A 121 PHE A 206 PHE A 210 TYR A 356 ILE A 378 PHE A 382 TYR A 386 GLY A 527 ALA A 528 SER A 531 GLY A 534 LEU A 535	BOG A 604 ( 3.7A) None EDO A 616 (-3.5A) IBP A 601 (-4.5A) None None IBP A 601 (-4.8A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) EDO A 616 (-3.0A) EDO A 616 ( 4.4A)	0.16A	4e1gB-4ph9A: 64.9	4e1gB-4ph9A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4E1G_B_LNLB701_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	8 / 12	ARG A 121 PHE A 211 TYR A 356 ILE A 378 PHE A 382 GLY A 527 ALA A 528 SER A 531	BOG A 604 ( 3.7A) HEM A 602 (-4.6A) IBP A 601 (-4.5A) None None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	1.37A	4e1gB-4ph9A: 64.9	4e1gB-4ph9A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4E1G_B_LNLB701_2 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	7 / 7	VAL A 345 TYR A 349 VAL A 350 LEU A 353 ASN A 376 MET A 523 VAL A 524	None None IBP A 601 (-4.3A) IBP A 601 ( 4.7A) EDO A 616 (-4.4A) None IBP A 601 ( 4.0A)	0.24A	4e1gB-4ph9A: 64.9	4e1gB-4ph9A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4M11_A_MXMA606_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	6 / 12	MET A 114 ARG A 121 VAL A 350 LEU A 360 ALA A 528 SER A 531	None BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	0.71A	4m11A-4ph9A: 63.5	4m11A-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4M11_A_MXMA606_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	MET A 114 LEU A 118 ARG A 121 ILE A 346 VAL A 350 LEU A 360 TRP A 388 MET A 523 ALA A 528	None None BOG A 604 ( 3.7A) None IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None None IBP A 601 (-3.4A)	0.53A	4m11A-4ph9A: 63.5	4m11A-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4M11_B_MXMB606_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	MET A 114 VAL A 117 ARG A 121 ILE A 346 LEU A 353 LEU A 360 TRP A 388 ALA A 528 LEU A 535	None BOG A 604 (-3.9A) BOG A 604 ( 3.7A) None IBP A 601 ( 4.7A) IBP A 601 ( 4.7A) None IBP A 601 (-3.4A) EDO A 616 ( 4.4A)	0.71A	4m11B-4ph9A: 63.5	4m11B-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4M11_B_MXMB606_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	7 / 12	MET A 114 VAL A 117 ARG A 121 ILE A 346 LEU A 353 LEU A 532 LEU A 535	None BOG A 604 (-3.9A) BOG A 604 ( 3.7A) None IBP A 601 ( 4.7A) IBP A 601 ( 4.9A) EDO A 616 ( 4.4A)	1.24A	4m11B-4ph9A: 63.5	4m11B-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4M11_B_MXMB606_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	MET A 114 VAL A 117 ARG A 121 ILE A 346 VAL A 350 LEU A 360 TRP A 388 ALA A 528 LEU A 535	None BOG A 604 (-3.9A) BOG A 604 ( 3.7A) None IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-3.4A) EDO A 616 ( 4.4A)	0.53A	4m11B-4ph9A: 63.5	4m11B-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4M11_B_MXMB606_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	8 / 12	MET A 114 VAL A 117 ARG A 121 LEU A 353 LEU A 360 TRP A 388 ALA A 528 SER A 531	None BOG A 604 (-3.9A) BOG A 604 ( 3.7A) IBP A 601 ( 4.7A) IBP A 601 ( 4.7A) None IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	0.87A	4m11B-4ph9A: 63.5	4m11B-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4M11_B_MXMB606_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	6 / 12	MET A 114 VAL A 117 ARG A 121 LEU A 353 SER A 531 LEU A 532	None BOG A 604 (-3.9A) BOG A 604 ( 3.7A) IBP A 601 ( 4.7A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	1.40A	4m11B-4ph9A: 63.5	4m11B-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4M11_B_MXMB606_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	8 / 12	MET A 114 VAL A 117 ARG A 121 VAL A 350 LEU A 360 TRP A 388 ALA A 528 SER A 531	None BOG A 604 (-3.9A) BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	0.73A	4m11B-4ph9A: 63.5	4m11B-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4M11_C_MXMC606_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	8 / 12	MET A 114 ILE A 346 VAL A 350 LEU A 360 TRP A 388 VAL A 524 ALA A 528 LEU A 535	None None IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A) EDO A 616 ( 4.4A)	0.36A	4m11C-4ph9A: 63.5	4m11C-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4M11_C_MXMC606_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	7 / 12	MET A 114 VAL A 117 ILE A 346 VAL A 350 LEU A 360 TRP A 388 LEU A 535	None BOG A 604 (-3.9A) None IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None EDO A 616 ( 4.4A)	0.57A	4m11C-4ph9A: 63.5	4m11C-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4M11_C_MXMC606_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	5 / 12	MET A 114 VAL A 117 VAL A 350 LEU A 360 SER A 531	None BOG A 604 (-3.9A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 ( 3.3A)	0.84A	4m11C-4ph9A: 63.5	4m11C-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4M11_C_MXMC606_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	6 / 12	MET A 114 VAL A 350 LEU A 360 VAL A 524 ALA A 528 SER A 531	None IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 ( 4.0A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	0.69A	4m11C-4ph9A: 63.5	4m11C-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4M11_D_MXMD606_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	5 / 12	MET A 114 LEU A 353 TRP A 388 VAL A 524 ALA A 528	None IBP A 601 ( 4.7A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A)	0.74A	4m11D-4ph9A: 63.6	4m11D-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4M11_D_MXMD606_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	MET A 114 VAL A 117 ARG A 121 ILE A 346 VAL A 350 LEU A 360 TRP A 388 VAL A 524 ALA A 528	None BOG A 604 (-3.9A) BOG A 604 ( 3.7A) None IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A)	0.54A	4m11D-4ph9A: 63.6	4m11D-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4M11_D_MXMD606_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	7 / 12	MET A 114 VAL A 117 ARG A 121 VAL A 350 LEU A 360 ALA A 528 SER A 531	None BOG A 604 (-3.9A) BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	0.78A	4m11D-4ph9A: 63.6	4m11D-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4O1Z_A_MXMA807_2 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	5 / 6	VAL A 117 LEU A 118 ARG A 121 LEU A 360 MET A 523	BOG A 604 (-3.9A) None BOG A 604 ( 3.7A) IBP A 601 ( 4.7A) None	0.64A	4o1zA-4ph9A: 58.8	4o1zA-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4O1Z_A_MXMA807_2 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	5 / 6	VAL A 117 LEU A 118 LEU A 360 PHE A 519 MET A 523	BOG A 604 (-3.9A) None IBP A 601 ( 4.7A) None None	0.77A	4o1zA-4ph9A: 58.8	4o1zA-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4O1Z_B_MXMB807_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	MET A 114 VAL A 117 LEU A 118 ARG A 121 ILE A 346 VAL A 350 LEU A 360 TRP A 388 PHE A 519 ALA A 528 SER A 531	None BOG A 604 (-3.9A) None BOG A 604 ( 3.7A) None IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None None IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	0.77A	4o1zB-4ph9A: 58.8	4o1zB-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4O1Z_B_MXMB807_1 (PROSTAGLANDIN G/H SYNTHASE 1)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	MET A 114 VAL A 117 LEU A 118 ARG A 121 TRP A 388 PHE A 519 ALA A 528 SER A 531 LEU A 532	None BOG A 604 (-3.9A) None BOG A 604 ( 3.7A) None None IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	1.07A	4o1zB-4ph9A: 58.8	4o1zB-4ph9A: 64.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OTY_A_LURA705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	6 / 12	LEU A 353 SER A 354 TYR A 356 LEU A 508 TRP A 388 VAL A 524	IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) None None IBP A 601 ( 4.0A)	1.49A	4otyA-4ph9A: 63.6	4otyA-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OTY_A_LURA705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	6 / 12	SER A 354 TYR A 356 LEU A 526 ALA A 528 SER A 531 LEU A 532	None IBP A 601 (-4.5A) None IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	1.11A	4otyA-4ph9A: 63.6	4otyA-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OTY_A_LURA705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	6 / 12	SER A 354 TYR A 356 LEU A 526 GLY A 527 ALA A 528 LEU A 532	None IBP A 601 (-4.5A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	1.36A	4otyA-4ph9A: 63.6	4otyA-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OTY_A_LURA705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 LEU A 385 TRP A 388 VAL A 524 GLY A 527 ALA A 528 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.59A	4otyA-4ph9A: 63.6	4otyA-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OTY_A_LURA705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.63A	4otyA-4ph9A: 63.6	4otyA-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OTY_A_LURA705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.37A	4otyA-4ph9A: 63.6	4otyA-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OTY_B_LURB705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	7 / 12	SER A 354 TYR A 356 LEU A 526 VAL A 524 ALA A 528 SER A 531 LEU A 532	None IBP A 601 (-4.5A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	1.27A	4otyB-4ph9A: 63.6	4otyB-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OTY_B_LURB705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	7 / 12	SER A 354 TYR A 356 LEU A 526 VAL A 524 GLY A 527 ALA A 528 LEU A 532	None IBP A 601 (-4.5A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	1.37A	4otyB-4ph9A: 63.6	4otyB-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OTY_B_LURB705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 LEU A 385 TRP A 388 VAL A 524 GLY A 527 ALA A 528 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.56A	4otyB-4ph9A: 63.6	4otyB-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OTY_B_LURB705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.58A	4otyB-4ph9A: 63.6	4otyB-4ph9A: 99.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OTY_B_LURB705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.33A	4otyB-4ph9A: 63.6	4otyB-4ph9A: 99.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	5 / 12	ASN A 196 GLY A 194 GLN A 193 LEU A 353 THR A 579	None None None IBP A 601 ( 4.7A) None	1.48A	4p6xG-4ph9A: undetectable	4p6xG-4ph9A: 19.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	5 / 12	ASN A 196 GLY A 194 GLN A 193 LEU A 353 THR A 579	None None None IBP A 601 ( 4.7A) None	1.45A	4p6xI-4ph9A: undetectable	4p6xI-4ph9A: 19.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRW_A_LURA705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 MET A 523 VAL A 524 GLY A 527 ALA A 528 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.56A	4rrwA-4ph9A: 63.7	4rrwA-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRW_A_LURA705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.73A	4rrwA-4ph9A: 63.7	4rrwA-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRW_B_LURB705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 MET A 523 VAL A 524 GLY A 527 ALA A 528 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.55A	4rrwB-4ph9A: 63.8	4rrwB-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRW_B_LURB705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.74A	4rrwB-4ph9A: 63.8	4rrwB-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRW_C_LURC705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 LEU A 385 VAL A 524 GLY A 527 ALA A 528 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.77A	4rrwC-4ph9A: 63.7	4rrwC-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRW_C_LURC705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.72A	4rrwC-4ph9A: 63.7	4rrwC-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRW_C_LURC705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	VAL A 350 SER A 354 TYR A 356 LEU A 526 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) None IBP A 601 (-4.5A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	1.32A	4rrwC-4ph9A: 63.7	4rrwC-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRW_D_LURD705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	8 / 12	LEU A 353 SER A 354 TYR A 356 LEU A 385 VAL A 524 GLY A 527 ALA A 528 LEU A 532	IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.65A	4rrwD-4ph9A: 63.8	4rrwD-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRW_D_LURD705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.59A	4rrwD-4ph9A: 63.8	4rrwD-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRW_D_LURD705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.36A	4rrwD-4ph9A: 63.8	4rrwD-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRW_D_LURD705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	8 / 12	VAL A 350 SER A 354 TYR A 356 LEU A 526 VAL A 524 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) None IBP A 601 (-4.5A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	1.22A	4rrwD-4ph9A: 63.8	4rrwD-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRW_D_LURD705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	8 / 12	VAL A 350 SER A 354 TYR A 356 LEU A 526 VAL A 524 GLY A 527 ALA A 528 LEU A 532	IBP A 601 (-4.3A) None IBP A 601 (-4.5A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	1.30A	4rrwD-4ph9A: 63.8	4rrwD-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRX_A_LURA706_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	TYR A 349 VAL A 350 LEU A 353 TYR A 356 LEU A 385 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 LEU A 532	None IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) None IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.58A	4rrxA-4ph9A: 63.2	4rrxA-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRX_A_LURA706_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	TYR A 349 VAL A 350 LEU A 353 TYR A 356 TYR A 386 TRP A 388 VAL A 524 ALA A 528 SER A 531 LEU A 532	None IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.72A	4rrxA-4ph9A: 63.2	4rrxA-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRX_B_LURB706_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	TYR A 349 VAL A 350 LEU A 353 TYR A 356 LEU A 385 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 LEU A 532	None IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) None IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.62A	4rrxB-4ph9A: 37.1	4rrxB-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRX_B_LURB706_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	TYR A 349 VAL A 350 LEU A 353 TYR A 356 TYR A 386 TRP A 388 VAL A 524 ALA A 528 SER A 531 LEU A 532	None IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.73A	4rrxB-4ph9A: 37.1	4rrxB-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRZ_A_LURA705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 MET A 523 VAL A 524 GLY A 527 ALA A 528 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.56A	4rrzA-4ph9A: 63.7	4rrzA-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRZ_A_LURA705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.73A	4rrzA-4ph9A: 63.7	4rrzA-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRZ_B_LURB705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 MET A 523 VAL A 524 GLY A 527 ALA A 528 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.55A	4rrzB-4ph9A: 63.8	4rrzB-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRZ_B_LURB705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.74A	4rrzB-4ph9A: 63.8	4rrzB-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRZ_C_LURC705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 LEU A 385 VAL A 524 GLY A 527 ALA A 528 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.77A	4rrzC-4ph9A: 63.7	4rrzC-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRZ_C_LURC705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.72A	4rrzC-4ph9A: 63.7	4rrzC-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRZ_C_LURC705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 12	VAL A 350 SER A 354 TYR A 356 LEU A 526 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) None IBP A 601 (-4.5A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	1.32A	4rrzC-4ph9A: 63.7	4rrzC-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRZ_D_LURD705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	8 / 12	LEU A 353 SER A 354 TYR A 356 LEU A 385 VAL A 524 GLY A 527 ALA A 528 LEU A 532	IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.65A	4rrzD-4ph9A: 63.8	4rrzD-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRZ_D_LURD705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.59A	4rrzD-4ph9A: 63.8	4rrzD-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRZ_D_LURD705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.36A	4rrzD-4ph9A: 63.8	4rrzD-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRZ_D_LURD705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	8 / 12	VAL A 350 SER A 354 TYR A 356 LEU A 526 VAL A 524 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) None IBP A 601 (-4.5A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	1.22A	4rrzD-4ph9A: 63.8	4rrzD-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RRZ_D_LURD705_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	8 / 12	VAL A 350 SER A 354 TYR A 356 LEU A 526 VAL A 524 GLY A 527 ALA A 528 LEU A 532	IBP A 601 (-4.3A) None IBP A 601 (-4.5A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	1.30A	4rrzD-4ph9A: 63.8	4rrzD-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RS0_A_IBPA706_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	9 / 9	ARG A 121 VAL A 350 LEU A 353 SER A 354 TYR A 356 LEU A 360 GLY A 527 ALA A 528 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.22A	4rs0A-4ph9A: 63.0	4rs0A-4ph9A: 99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5F1A_A_SALA601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	5 / 8	LEU A 353 LEU A 385 TYR A 386 TRP A 388 GLY A 527	IBP A 601 ( 4.7A) None IBP A 601 (-4.8A) None IBP A 601 (-3.9A)	0.69A	5f1aA-4ph9A: 63.4	5f1aA-4ph9A: 88.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5F1A_A_SALA601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	6 / 8	VAL A 350 LEU A 385 TYR A 386 TRP A 388 GLY A 527 ALA A 528	IBP A 601 (-4.3A) None IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A)	0.20A	5f1aA-4ph9A: 63.4	5f1aA-4ph9A: 88.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5F1A_A_SALA601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	4 / 8	VAL A 350 TYR A 386 ALA A 528 SER A 531	IBP A 601 (-4.3A) IBP A 601 (-4.8A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	0.74A	5f1aA-4ph9A: 63.4	5f1aA-4ph9A: 88.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5F1A_B_SALB601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	6 / 7	VAL A 350 LEU A 385 TYR A 386 TRP A 388 GLY A 527 ALA A 528	IBP A 601 (-4.3A) None IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A)	0.17A	5f1aB-4ph9A: 63.4	5f1aB-4ph9A: 88.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5F1A_B_SALB601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	5 / 7	VAL A 350 TYR A 386 TRP A 388 ALA A 528 SER A 531	IBP A 601 (-4.3A) IBP A 601 (-4.8A) None IBP A 601 (-3.4A) IBP A 601 ( 3.3A)	0.64A	5f1aB-4ph9A: 63.4	5f1aB-4ph9A: 88.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5F9Z_A_HFGA702_0 (AMINOACYL-TRNA SYNTHETASE)	2wd9	ACYL-COENZYME A SYNTHETASE ACSM2A, MITOCHONDRIAL (Homo sapiens)	5 / 12	LEU A 267 GLY A 470 GLU A 339 VAL A 337 PHE A 291	IBP A1570 (-3.7A) None None IBP A1570 (-4.6A) None	1.27A	5f9zA-2wd9A: undetectable	5f9zA-2wd9A: 23.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IKQ_A_JMSA602_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 385 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) None IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.36A	5ikqA-4ph9A: 62.7	5ikqA-4ph9A: 88.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IKQ_A_JMSA602_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	ARG A 121 VAL A 350 LEU A 353 TYR A 356 TYR A 386 TRP A 388 VAL A 524 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.61A	5ikqA-4ph9A: 62.7	5ikqA-4ph9A: 88.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IKQ_B_JMSB602_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 385 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) None IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.32A	5ikqB-4ph9A: 62.9	5ikqB-4ph9A: 88.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IKQ_B_JMSB602_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	ARG A 121 VAL A 350 LEU A 353 TYR A 356 TYR A 386 TRP A 388 VAL A 524 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.61A	5ikqB-4ph9A: 62.9	5ikqB-4ph9A: 88.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IKR_A_ID8A601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	ARG A 121 VAL A 350 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.61A	5ikrA-4ph9A: 63.0	5ikrA-4ph9A: 88.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IKR_A_ID8A601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	ARG A 121 VAL A 350 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.33A	5ikrA-4ph9A: 63.0	5ikrA-4ph9A: 88.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IKR_A_ID8A601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 ALA A 528 SER A 531 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.72A	5ikrA-4ph9A: 63.0	5ikrA-4ph9A: 88.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IKR_A_ID8A601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	VAL A 350 LEU A 353 SER A 354 TYR A 356 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 LEU A 532	IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.50A	5ikrA-4ph9A: 63.0	5ikrA-4ph9A: 88.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IKR_B_ID8B602_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 VAL A 524 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.66A	5ikrB-4ph9A: 62.8	5ikrB-4ph9A: 88.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IKR_B_ID8B602_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.44A	5ikrB-4ph9A: 62.8	5ikrB-4ph9A: 88.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IKT_A_TLFA601_0 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	VAL A 117 ARG A 121 VAL A 350 SER A 354 TYR A 356 LEU A 385 TRP A 388 MET A 523 VAL A 524 GLY A 527 ALA A 528 LEU A 532	BOG A 604 (-3.9A) BOG A 604 ( 3.7A) IBP A 601 (-4.3A) None IBP A 601 (-4.5A) None None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.49A	5iktA-4ph9A: 63.1	5iktA-4ph9A: 88.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IKT_B_TLFB601_0 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	10 / 12	VAL A 117 ARG A 121 VAL A 350 LEU A 385 TRP A 388 MET A 523 VAL A 524 GLY A 527 ALA A 528 LEU A 532	BOG A 604 (-3.9A) BOG A 604 ( 3.7A) IBP A 601 (-4.3A) None None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.39A	5iktB-4ph9A: 63.1	5iktB-4ph9A: 88.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IKT_B_TLFB601_0 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	VAL A 117 VAL A 350 LEU A 353 SER A 354 LEU A 385 TRP A 388 MET A 523 VAL A 524 GLY A 527 ALA A 528 LEU A 532	BOG A 604 (-3.9A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) None None None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.33A	5iktB-4ph9A: 63.1	5iktB-4ph9A: 88.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IKT_B_TLFB601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	3 / 3	TYR A 356 TYR A 386 SER A 531	IBP A 601 (-4.5A) IBP A 601 (-4.8A) IBP A 601 ( 3.3A)	0.83A	5iktB-4ph9A: 63.1	5iktB-4ph9A: 88.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JVZ_A_FLPA601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	ARG A 121 VAL A 350 LEU A 353 TYR A 356 LEU A 360 TYR A 386 TRP A 388 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.47A	5jvzA-4ph9A: 64.0	5jvzA-4ph9A: 99.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JVZ_B_FLPB601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	ARG A 121 LEU A 353 SER A 354 TYR A 356 LEU A 360 TYR A 386 TRP A 388 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 ( 4.7A) None IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.55A	5jvzB-4ph9A: 64.0	5jvzB-4ph9A: 99.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JVZ_B_FLPB601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	ARG A 121 VAL A 350 SER A 354 TYR A 356 LEU A 360 TYR A 386 TRP A 388 GLY A 527 ALA A 528 SER A 531 LEU A 532	BOG A 604 ( 3.7A) IBP A 601 (-4.3A) None IBP A 601 (-4.5A) IBP A 601 ( 4.7A) IBP A 601 (-4.8A) None IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.23A	5jvzB-4ph9A: 64.0	5jvzB-4ph9A: 99.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JW1_A_CELA602_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	HIS A 90 GLN A 193 VAL A 350 TYR A 356 LEU A 360 TRP A 388 ALA A 517 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	None None IBP A 601 (-4.3A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.42A	5jw1A-4ph9A: 62.6	5jw1A-4ph9A: 99.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JW1_A_CELA602_2 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	6 / 6	VAL A 117 LEU A 353 SER A 354 ARG A 514 ILE A 518 PHE A 519	BOG A 604 (-3.9A) IBP A 601 ( 4.7A) None None None None	0.47A	5jw1A-4ph9A: 62.6	5jw1A-4ph9A: 99.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JW1_B_CELB602_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	HIS A 90 ARG A 121 GLN A 193 LEU A 353 TYR A 356 LEU A 360 TRP A 388 ALA A 517 VAL A 524 GLY A 527 ALA A 528	None BOG A 604 ( 3.7A) None IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A)	0.76A	5jw1B-4ph9A: 62.7	5jw1B-4ph9A: 99.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JW1_B_CELB602_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	11 / 12	HIS A 90 GLN A 193 LEU A 353 TYR A 356 LEU A 360 TRP A 388 ALA A 517 VAL A 524 GLY A 527 ALA A 528 LEU A 532	None None IBP A 601 ( 4.7A) IBP A 601 (-4.5A) IBP A 601 ( 4.7A) None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 4.9A)	0.35A	5jw1B-4ph9A: 62.7	5jw1B-4ph9A: 99.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JW1_B_CELB602_2 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	6 / 6	VAL A 117 VAL A 350 SER A 354 ARG A 514 ILE A 518 PHE A 519	BOG A 604 (-3.9A) IBP A 601 (-4.3A) None None None None	0.30A	5jw1B-4ph9A: 62.7	5jw1B-4ph9A: 99.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5KIR_A_RCXA601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	HIS A 90 GLN A 193 VAL A 350 LEU A 353 TYR A 356 TRP A 388 ALA A 517 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	None None IBP A 601 (-4.3A) IBP A 601 ( 4.7A) IBP A 601 (-4.5A) None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.25A	5kirA-4ph9A: 62.4	5kirA-4ph9A: 87.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5KIR_B_RCXB601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	6 / 12	ALA A 436 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	1.43A	5kirB-4ph9A: 63.0	5kirB-4ph9A: 87.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5KIR_B_RCXB601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	12 / 12	HIS A 90 GLN A 193 VAL A 350 SER A 354 TYR A 356 TRP A 388 ALA A 517 VAL A 524 GLY A 527 ALA A 528 SER A 531 LEU A 532	None None IBP A 601 (-4.3A) None IBP A 601 (-4.5A) None None IBP A 601 ( 4.0A) IBP A 601 (-3.9A) IBP A 601 (-3.4A) IBP A 601 ( 3.3A) IBP A 601 ( 4.9A)	0.32A	5kirB-4ph9A: 63.0	5kirB-4ph9A: 87.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5KIR_B_RCXB601_2 (PROSTAGLANDIN G/H SYNTHASE 2)	4ph9	PROSTAGLANDIN G/H SYNTHASE 2 (Mus musculus)	4 / 4	LEU A 353 ARG A 514 ILE A 518 PHE A 519	IBP A 601 ( 4.7A) None None None	0.34A	5kirB-4ph9A: 63.0	5kirB-4ph9A: 87.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NWV_A_ACAA18_1 (SCRFP-TAG,GP41)	2wd9	ACYL-COENZYME A SYNTHETASE ACSM2A, MITOCHONDRIAL (Homo sapiens)	5 / 12	LEU A 251 GLY A 247 GLU A 275 LEU A 270 LEU A 368	None None None None IBP A1570 ( 4.4A)	1.17A	5nwvA-2wd9A: undetectable	5nwvA-2wd9A: 6.77

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1CQE_A_FLPA1650_1","PROTEIN (PROSTAGLANDIN H2 SYNTHASE-1)","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.41A","1cqeA-4ph9A:59.1",null],["1CQE_B_FLPB2650_1","PROTEIN (PROSTAGLANDIN H2 SYNTHASE-1)","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.42A","1cqeB-4ph9A:59.2","1cqeA-4ph9A:63.06"],["1EQG_A_IBPA701_1","PROSTAGLANDIN H2 SYNTHASE-1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",8,"VAL A 117;ARG A 121;VAL A 350;TYR A 356;LEU A 360;ALA A 528;SER A 531;LEU A 532","BOG A 604 (-3.9A);BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.55A","1eqgA-4ph9A:59.2","1cqeB-4ph9A:63.06"],["1EQG_B_IBPB1701_1","PROSTAGLANDIN H2 SYNTHASE-1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 117;ARG A 121;VAL A 350;SER A 354;TYR A 356;LEU A 360;TYR A 386;ALA A 528;SER A 531;LEU A 532","BOG A 604 (-3.9A);BOG A 604 ( 3.7A);IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.50A","1eqgB-4ph9A:59.3","1eqgA-4ph9A:63.06"],["1EQH_A_FLPA701_1","PROSTAGLANDIN H2 SYNTHASE-1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"VAL A 117;ARG A 121;VAL A 350;TYR A 356;LEU A 360;TYR A 386;TRP A 388;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 (-3.9A);BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.28A","1eqhA-4ph9A:59.5","1eqgB-4ph9A:63.06"],["1EQH_B_FLPB1701_1","PROSTAGLANDIN H2 SYNTHASE-1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"VAL A 117;ARG A 121;VAL A 350;TYR A 356;LEU A 360;TYR A 386;TRP A 388;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 (-3.9A);BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.32A","1eqhB-4ph9A:59.5","1eqhA-4ph9A:63.06"],["1FE2_A_LAXA700_1","PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"VAL A 117;ARG A 121;PHE A 206;VAL A 229;VAL A 345;TYR A 349;VAL A 350;ASN A 376;LEU A 532","BOG A 604 (-3.9A);BOG A 604 ( 3.7A);None;None;None;None;IBP A 601 (-4.3A);EDO A 616 (-4.4A);IBP A 601 ( 4.9A)","0.41A","1fe2A-4ph9A:58.4","1eqhB-4ph9A:63.06"],["1FE2_A_LAXA700_2","PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",6,"PHE A 206;TYR A 386;TRP A 388;GLY A 527;ALA A 528;SER A 531","None;IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","1.29A","1fe2A-4ph9A:58.4","1fe2A-4ph9A:63.51"],["1FE2_A_LAXA700_2","PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"PHE A 210;LEU A 353;PHE A 382;TYR A 386;TRP A 388;PHE A 519;GLY A 527;ALA A 528;SER A 531;GLY A 534;LEU A 535","EDO A 616 (-3.5A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.8A);None;None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);EDO A 616 (-3.0A);EDO A 616 ( 4.4A)","0.64A","1fe2A-4ph9A:58.4","1fe2A-4ph9A:63.51"],["1FE2_A_LAXA700_2","PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"PHE A 210;LEU A 353;TYR A 356;PHE A 382;TYR A 386;TRP A 388;GLY A 527;ALA A 528;SER A 531;GLY A 534;LEU A 535","EDO A 616 (-3.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);None;IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);EDO A 616 (-3.0A);EDO A 616 ( 4.4A)","0.37A","1fe2A-4ph9A:58.4","1fe2A-4ph9A:63.51"],["1IGX_A_EPAA700_1","PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"PHE A 206;PHE A 210;LEU A 353;TYR A 356;PHE A 382;TYR A 386;TRP A 388;GLY A 527;ALA A 528;SER A 531;GLY A 534;LEU A 535","None;EDO A 616 (-3.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);None;IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);EDO A 616 (-3.0A);EDO A 616 ( 4.4A)","0.53A","1igxA-4ph9A:58.1","1fe2A-4ph9A:63.51"],["1IGX_A_EPAA700_1","PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",6,"PHE A 211;LEU A 353;TYR A 356;PHE A 382;ALA A 528;SER A 531","HEM A 602 (-4.6A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);None;IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","1.50A","1igxA-4ph9A:58.1","1igxA-4ph9A:63.51"],["1PTH_A_SALA710_1","PROSTAGLANDIN H2 SYNTHASE-1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",7,"VAL A 117;ARG A 121;VAL A 350;LEU A 353;TYR A 356;ALA A 528;LEU A 532","BOG A 604 (-3.9A);BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.53A","1pthA-4ph9A:58.7","1igxA-4ph9A:63.51"],["1PTH_B_SALB711_1","PROSTAGLANDIN H2 SYNTHASE-1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",7,"VAL A 117;ARG A 121;VAL A 350;LEU A 353;TYR A 356;ALA A 528;LEU A 532","BOG A 604 (-3.9A);BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.53A","1pthB-4ph9A:58.7","1pthA-4ph9A:63.51"],["1PXX_A_DIFA701_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 350;LEU A 353;LEU A 385;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.53A","1pxxA-4ph9A:63.3","1pthB-4ph9A:63.51"],["1PXX_B_DIFB1701_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"VAL A 350;LEU A 353;LEU A 385;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","0.51A","1pxxB-4ph9A:63.3","1pxxA-4ph9A:96.65"],["1PXX_C_DIFC2701_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"VAL A 350;LEU A 353;SER A 354;TYR A 356;LEU A 385;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);None;IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.51A","1pxxC-4ph9A:63.4","1pxxB-4ph9A:96.65"],["1PXX_D_DIFD3701_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 350;LEU A 353;TYR A 356;LEU A 385;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);None;IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","0.48A","1pxxD-4ph9A:63.3","1pxxC-4ph9A:96.65"],["2A58_D_RBFD303_1","6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE;6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE","2wd9","ACYL-COENZYME A SYNTHETASE ACSM2A, MITOCHONDRIAL","Homo sapiens",5,"ILE A 412;TRP A 442;GLY A 362;LEU A 270;HIS A 233","None;None;IBP A1570 (-3.9A);None;None","1.45A","2a58C-2wd9A:3.1;2a58D-2wd9A:2.3","1pxxD-4ph9A:96.65"],["2AYL_A_FLPA1701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.64A","2aylA-4ph9A:59.3","2a58C-2wd9A:14.24;2a58D-2wd9A:14.24"],["2AYL_A_FLPA1701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;GLY A 527;ALA A 528;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.45A","2aylA-4ph9A:59.3","2aylA-4ph9A:64.31"],["2AYL_A_FLPA1701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"VAL A 350;LEU A 353;LEU A 360;TYR A 386;TRP A 388;PHE A 519;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;None;IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.88A","2aylA-4ph9A:59.3","2aylA-4ph9A:64.31"],["2AYL_A_FLPA1701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"VAL A 350;LEU A 353;LEU A 360;TYR A 386;TRP A 388;PHE A 519;GLY A 527;ALA A 528;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.74A","2aylA-4ph9A:59.3","2aylA-4ph9A:64.31"],["2AYL_B_FLPB2701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.57A","2aylB-4ph9A:59.4","2aylA-4ph9A:64.31"],["2AYL_B_FLPB2701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;GLY A 527;ALA A 528;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.32A","2aylB-4ph9A:59.4","2aylB-4ph9A:64.31"],["2QD5_B_CHDB1103_0","FERROCHELATASE","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",4,"LEU A 360;SER A 120;VAL A 524;GLY A 527","IBP A 601 ( 4.7A);BOG A 604 (-2.8A);IBP A 601 ( 4.0A);IBP A 601 (-3.9A)","1.04A","2qd5B-4ph9A:undetectable","2aylB-4ph9A:64.31"],["3HS6_A_EPAA1_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 117;VAL A 350;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;LEU A 535","BOG A 604 (-3.9A);IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);EDO A 616 ( 4.4A)","0.37A","3hs6A-4ph9A:63.3","2qd5B-4ph9A:21.78"],["3HS6_A_EPAA1_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 117;VAL A 350;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531","BOG A 604 (-3.9A);IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","0.62A","3hs6A-4ph9A:63.3","3hs6A-4ph9A:99.28"],["3HS6_B_EPAB1_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"PHE A 210;GLY A 228;TYR A 356;ASN A 376;ILE A 378;PHE A 382;ALA A 528;SER A 531;GLY A 534","EDO A 616 (-3.5A);EDO A 616 ( 4.5A);IBP A 601 (-4.5A);EDO A 616 (-4.4A);None;None;IBP A 601 (-3.4A);IBP A 601 ( 3.3A);EDO A 616 (-3.0A)","0.72A","3hs6B-4ph9A:63.6","3hs6A-4ph9A:99.28"],["3HS6_B_EPAB1_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"PHE A 210;GLY A 228;TYR A 356;ASN A 376;ILE A 378;PHE A 382;TYR A 386;GLY A 527;ALA A 528;GLY A 534;LEU A 535","EDO A 616 (-3.5A);EDO A 616 ( 4.5A);IBP A 601 (-4.5A);EDO A 616 (-4.4A);None;None;IBP A 601 (-4.8A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);EDO A 616 (-3.0A);EDO A 616 ( 4.4A)","0.38A","3hs6B-4ph9A:63.6","3hs6B-4ph9A:99.28"],["3HS6_B_EPAB1_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",6,"PHE A 211;TYR A 356;ILE A 378;PHE A 382;ALA A 528;SER A 531","HEM A 602 (-4.6A);IBP A 601 (-4.5A);None;None;IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","1.29A","3hs6B-4ph9A:63.6","3hs6B-4ph9A:99.28"],["3HS6_B_EPAB1_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",6,"PHE A 211;TYR A 356;ILE A 378;PHE A 382;GLY A 527;ALA A 528","HEM A 602 (-4.6A);IBP A 601 (-4.5A);None;None;IBP A 601 (-3.9A);IBP A 601 (-3.4A)","1.37A","3hs6B-4ph9A:63.6","3hs6B-4ph9A:99.28"],["3KK6_A_CELA701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",7,"GLN A 193;VAL A 350;LEU A 353;TRP A 388;PHE A 519;GLY A 527;SER A 531","None;IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;None;IBP A 601 (-3.9A);IBP A 601 ( 3.3A)","0.93A","3kk6A-4ph9A:57.1","3hs6B-4ph9A:99.28"],["3KK6_A_CELA701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"GLN A 193;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TRP A 388;GLY A 527;ALA A 528;SER A 531","None;IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","0.71A","3kk6A-4ph9A:57.1","3kk6A-4ph9A:64.31"],["3KK6_B_CELB1701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",7,"GLN A 193;VAL A 350;LEU A 353;TRP A 388;PHE A 519;GLY A 527;SER A 531","None;IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;None;IBP A 601 (-3.9A);IBP A 601 ( 3.3A)","0.90A","3kk6B-4ph9A:56.8","3kk6A-4ph9A:64.31"],["3KK6_B_CELB1701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"HIS A  90;GLN A 193;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TRP A 388;GLY A 527;SER A 531","None;None;IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);None;IBP A 601 (-3.9A);IBP A 601 ( 3.3A)","0.64A","3kk6B-4ph9A:56.8","3kk6B-4ph9A:64.31"],["3LN1_A_CELA682_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"HIS A  90;GLN A 193;VAL A 350;TYR A 356;LEU A 360;TRP A 388;ALA A 517;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","None;None;IBP A 601 (-4.3A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.53A","3ln1A-4ph9A:63.8","3kk6B-4ph9A:64.31"],["3LN1_B_CELB682_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"HIS A  90;GLN A 193;VAL A 350;TYR A 356;LEU A 360;TRP A 388;ALA A 517;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","None;None;IBP A 601 (-4.3A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.53A","3ln1B-4ph9A:63.9","3ln1A-4ph9A:99.64"],["3LN1_C_CELC682_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"HIS A  90;VAL A 350;TYR A 356;LEU A 360;TYR A 386;TRP A 388;ALA A 517;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","None;IBP A 601 (-4.3A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.52A","3ln1C-4ph9A:63.8","3ln1B-4ph9A:99.64"],["3LN1_D_CELD682_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"HIS A  90;GLN A 193;VAL A 350;SER A 354;TYR A 356;LEU A 360;TRP A 388;ALA A 517;VAL A 524;GLY A 527;ALA A 528;LEU A 532","None;None;IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);IBP A 601 ( 4.7A);None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.32A","3ln1D-4ph9A:63.8","3ln1C-4ph9A:99.64"],["3N8W_A_FLPA701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"VAL A 117;ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 (-3.9A);BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.47A","3n8wA-4ph9A:58.7","3ln1D-4ph9A:99.64"],["3N8X_A_NIMA701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"HIS A  90;ARG A 121;LEU A 353;TYR A 356;TYR A 386;TRP A 388;GLY A 527;ALA A 528;SER A 531;LEU A 532","None;BOG A 604 ( 3.7A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.62A","3n8xA-4ph9A:11.5","3n8wA-4ph9A:64.31"],["3N8X_A_NIMA701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"HIS A  90;LEU A 353;TYR A 356;TYR A 386;TRP A 388;PHE A 519;GLY A 527;SER A 531;LEU A 532","None;IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;None;IBP A 601 (-3.9A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.72A","3n8xA-4ph9A:11.5","3n8xA-4ph9A:64.31"],["3N8X_B_NIMB1701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"HIS A  90;ARG A 121;LEU A 353;TYR A 356;LEU A 360;TRP A 388;GLY A 527;ALA A 528;SER A 531;LEU A 532","None;BOG A 604 ( 3.7A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.61A","3n8xB-4ph9A:57.9","3n8xA-4ph9A:64.31"],["3N8X_B_NIMB1701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",8,"LEU A 353;TYR A 356;LEU A 360;TRP A 388;PHE A 519;GLY A 527;SER A 531;LEU A 532","IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);None;None;IBP A 601 (-3.9A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.73A","3n8xB-4ph9A:57.9","3n8xB-4ph9A:64.31"],["3N8X_B_NIMB1701_2","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",3,"VAL A 117;VAL A 350;SER A 354","BOG A 604 (-3.9A);IBP A 601 (-4.3A);None","0.12A","3n8xB-4ph9A:57.9","3n8xB-4ph9A:64.31"],["3N8Y_A_DIFA701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.80A","3n8yA-4ph9A:34.1","3n8xB-4ph9A:64.31"],["3N8Y_A_DIFA701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;GLY A 527;ALA A 528;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.61A","3n8yA-4ph9A:34.1","3n8yA-4ph9A:64.31"],["3N8Y_B_DIFB585_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"VAL A 345;VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;GLY A 527;ALA A 528;LEU A 532;LEU A 535","None;IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A);EDO A 616 ( 4.4A)","0.47A","3n8yB-4ph9A:32.9","3n8yA-4ph9A:64.31"],["3N8Y_B_SALB900_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",4,"VAL A 350;LEU A 353;TYR A 356;ALA A 528","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 (-3.4A)","0.45A","3n8yB-4ph9A:32.9","3n8yB-4ph9A:64.31"],["3N8Z_A_FLPA701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"VAL A 117;ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 (-3.9A);BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.55A","3n8zA-4ph9A:58.5","3n8yB-4ph9A:64.31"],["3N8Z_B_FLPB1701_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 385;TYR A 386;TRP A 388;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);None;IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.57A","3n8zB-4ph9A:58.6","3n8zA-4ph9A:64.31"],["3NT1_A_NPSA5_1","PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","0.65A","3nt1A-4ph9A:64.9","3n8zB-4ph9A:64.31"],["3NT1_A_NPSA5_1","PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"ARG A 121;VAL A 350;TYR A 356;LEU A 360;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.46A","3nt1A-4ph9A:64.9","3nt1A-4ph9A:99.64"],["3NT1_B_NPSB4_1","PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"ARG A 121;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531","BOG A 604 ( 3.7A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","0.70A","3nt1B-4ph9A:65.0","3nt1A-4ph9A:99.64"],["3NT1_B_NPSB4_1","PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"ARG A 121;VAL A 350;TYR A 356;LEU A 360;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.46A","3nt1B-4ph9A:65.0","3nt1B-4ph9A:99.64"],["3PGH_A_FLPA701_1","CYCLOOXYGENASE-2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"VAL A 117;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;VAL A 524;ALA A 528;SER A 531;LEU A 532","BOG A 604 (-3.9A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.54A","3pghA-4ph9A:63.3","3nt1B-4ph9A:99.64"],["3PGH_A_FLPA701_1","CYCLOOXYGENASE-2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"VAL A 117;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;LEU A 532","BOG A 604 (-3.9A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.37A","3pghA-4ph9A:63.3","3pghA-4ph9A:99.27"],["3PGH_B_FLPB701_1","CYCLOOXYGENASE-2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;MET A 523;VAL A 524;GLY A 527;ALA A 528","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A)","0.42A","3pghB-4ph9A:25.4","3pghA-4ph9A:99.27"],["3PGH_C_FLPC701_1","CYCLOOXYGENASE-2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"VAL A 117;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 (-3.9A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.52A","3pghC-4ph9A:63.3","3pghB-4ph9A:99.27"],["3PGH_D_FLPD701_1","CYCLOOXYGENASE-2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.56A","3pghD-4ph9A:63.3","3pghC-4ph9A:99.27"],["3RR3_A_FLRA700_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"VAL A 117;ARG A 121;VAL A 350;TYR A 356;LEU A 360;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 (-3.9A);BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.43A","3rr3A-4ph9A:63.6","3pghD-4ph9A:99.27"],["3RR3_B_FLRB700_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"VAL A 117;ARG A 121;VAL A 350;TYR A 356;LEU A 360;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 (-3.9A);BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.44A","3rr3B-4ph9A:63.6","3rr3A-4ph9A:99.64"],["3RR3_C_FLRC700_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"VAL A 117;ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531","BOG A 604 (-3.9A);BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","0.60A","3rr3C-4ph9A:63.6","3rr3B-4ph9A:99.64"],["3RR3_D_FLRD700_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"VAL A 117;ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531","BOG A 604 (-3.9A);BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","0.60A","3rr3D-4ph9A:63.6","3rr3C-4ph9A:99.64"],["4COX_A_IMNA701_1","CYCLOOXYGENASE-2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"ARG A 121;VAL A 350;SER A 354;TYR A 356;LEU A 385;VAL A 524;GLY A 527;ALA A 528;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.70A","4coxA-4ph9A:62.8","3rr3D-4ph9A:99.64"],["4COX_A_IMNA701_1","CYCLOOXYGENASE-2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"ARG A 121;VAL A 350;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.59A","4coxA-4ph9A:62.8","4coxA-4ph9A:99.27"],["4COX_A_IMNA701_1","CYCLOOXYGENASE-2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",8,"VAL A 350;SER A 354;TYR A 356;LEU A 526;GLY A 527;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","1.25A","4coxA-4ph9A:62.8","4coxA-4ph9A:99.27"],["4COX_B_IMNB701_1","CYCLOOXYGENASE-2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"ARG A 121;VAL A 350;SER A 354;TYR A 356;LEU A 385;VAL A 524;GLY A 527;ALA A 528;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.69A","4coxB-4ph9A:62.6","4coxA-4ph9A:99.27"],["4COX_B_IMNB701_1","CYCLOOXYGENASE-2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"ARG A 121;VAL A 350;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.58A","4coxB-4ph9A:62.6","4coxB-4ph9A:99.27"],["4COX_B_IMNB701_1","CYCLOOXYGENASE-2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"VAL A 350;SER A 354;TYR A 356;LEU A 526;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","1.26A","4coxB-4ph9A:62.6","4coxB-4ph9A:99.27"],["4COX_C_IMNC701_1","CYCLOOXYGENASE-2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"ARG A 121;VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.56A","4coxC-4ph9A:62.6","4coxB-4ph9A:99.27"],["4COX_D_IMND701_1","CYCLOOXYGENASE-2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"ARG A 121;VAL A 350;SER A 354;TYR A 356;LEU A 385;VAL A 524;GLY A 527;ALA A 528;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.70A","4coxD-4ph9A:62.8","4coxC-4ph9A:99.27"],["4COX_D_IMND701_1","CYCLOOXYGENASE-2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"ARG A 121;VAL A 350;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.59A","4coxD-4ph9A:62.8","4coxD-4ph9A:99.27"],["4COX_D_IMND701_1","CYCLOOXYGENASE-2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"VAL A 350;SER A 354;TYR A 356;LEU A 526;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","1.27A","4coxD-4ph9A:62.8","4coxD-4ph9A:99.27"],["4E1G_A_LNLA701_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"PHE A 206;PHE A 210;TYR A 356;ASN A 376;ILE A 378;PHE A 382;TYR A 386;GLY A 527;ALA A 528;SER A 531;GLY A 534;LEU A 535","None;EDO A 616 (-3.5A);IBP A 601 (-4.5A);EDO A 616 (-4.4A);None;None;IBP A 601 (-4.8A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);EDO A 616 (-3.0A);EDO A 616 ( 4.4A)","0.28A","4e1gA-4ph9A:64.6","4coxD-4ph9A:99.27"],["4E1G_A_LNLA701_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",7,"PHE A 211;TYR A 356;ILE A 378;PHE A 382;GLY A 527;ALA A 528;SER A 531","HEM A 602 (-4.6A);IBP A 601 (-4.5A);None;None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","1.31A","4e1gA-4ph9A:64.6","4e1gA-4ph9A:100.00"],["4E1G_A_LNLA701_2","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",5,"ARG A 121;VAL A 350;LEU A 353;SER A 354;MET A 523","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;None","0.20A","4e1gA-4ph9A:64.6","4e1gA-4ph9A:100.00"],["4E1G_B_LNLB701_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"ARG A 121;PHE A 206;PHE A 210;TYR A 356;ILE A 378;PHE A 382;TYR A 386;GLY A 527;ALA A 528;SER A 531;GLY A 534;LEU A 535","BOG A 604 ( 3.7A);None;EDO A 616 (-3.5A);IBP A 601 (-4.5A);None;None;IBP A 601 (-4.8A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);EDO A 616 (-3.0A);EDO A 616 ( 4.4A)","0.16A","4e1gB-4ph9A:64.9","4e1gA-4ph9A:100.00"],["4E1G_B_LNLB701_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",8,"ARG A 121;PHE A 211;TYR A 356;ILE A 378;PHE A 382;GLY A 527;ALA A 528;SER A 531","BOG A 604 ( 3.7A);HEM A 602 (-4.6A);IBP A 601 (-4.5A);None;None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","1.37A","4e1gB-4ph9A:64.9","4e1gB-4ph9A:100.00"],["4E1G_B_LNLB701_2","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",7,"VAL A 345;TYR A 349;VAL A 350;LEU A 353;ASN A 376;MET A 523;VAL A 524","None;None;IBP A 601 (-4.3A);IBP A 601 ( 4.7A);EDO A 616 (-4.4A);None;IBP A 601 ( 4.0A)","0.24A","4e1gB-4ph9A:64.9","4e1gB-4ph9A:100.00"],["4M11_A_MXMA606_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",6,"MET A 114;ARG A 121;VAL A 350;LEU A 360;ALA A 528;SER A 531","None;BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","0.71A","4m11A-4ph9A:63.5","4e1gB-4ph9A:100.00"],["4M11_A_MXMA606_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"MET A 114;LEU A 118;ARG A 121;ILE A 346;VAL A 350;LEU A 360;TRP A 388;MET A 523;ALA A 528","None;None;BOG A 604 ( 3.7A);None;IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;None;IBP A 601 (-3.4A)","0.53A","4m11A-4ph9A:63.5","4m11A-4ph9A:99.64"],["4M11_B_MXMB606_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"MET A 114;VAL A 117;ARG A 121;ILE A 346;LEU A 353;LEU A 360;TRP A 388;ALA A 528;LEU A 535","None;BOG A 604 (-3.9A);BOG A 604 ( 3.7A);None;IBP A 601 ( 4.7A);IBP A 601 ( 4.7A);None;IBP A 601 (-3.4A);EDO A 616 ( 4.4A)","0.71A","4m11B-4ph9A:63.5","4m11A-4ph9A:99.64"],["4M11_B_MXMB606_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",7,"MET A 114;VAL A 117;ARG A 121;ILE A 346;LEU A 353;LEU A 532;LEU A 535","None;BOG A 604 (-3.9A);BOG A 604 ( 3.7A);None;IBP A 601 ( 4.7A);IBP A 601 ( 4.9A);EDO A 616 ( 4.4A)","1.24A","4m11B-4ph9A:63.5","4m11B-4ph9A:99.64"],["4M11_B_MXMB606_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"MET A 114;VAL A 117;ARG A 121;ILE A 346;VAL A 350;LEU A 360;TRP A 388;ALA A 528;LEU A 535","None;BOG A 604 (-3.9A);BOG A 604 ( 3.7A);None;IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-3.4A);EDO A 616 ( 4.4A)","0.53A","4m11B-4ph9A:63.5","4m11B-4ph9A:99.64"],["4M11_B_MXMB606_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",8,"MET A 114;VAL A 117;ARG A 121;LEU A 353;LEU A 360;TRP A 388;ALA A 528;SER A 531","None;BOG A 604 (-3.9A);BOG A 604 ( 3.7A);IBP A 601 ( 4.7A);IBP A 601 ( 4.7A);None;IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","0.87A","4m11B-4ph9A:63.5","4m11B-4ph9A:99.64"],["4M11_B_MXMB606_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",6,"MET A 114;VAL A 117;ARG A 121;LEU A 353;SER A 531;LEU A 532","None;BOG A 604 (-3.9A);BOG A 604 ( 3.7A);IBP A 601 ( 4.7A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","1.40A","4m11B-4ph9A:63.5","4m11B-4ph9A:99.64"],["4M11_B_MXMB606_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",8,"MET A 114;VAL A 117;ARG A 121;VAL A 350;LEU A 360;TRP A 388;ALA A 528;SER A 531","None;BOG A 604 (-3.9A);BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","0.73A","4m11B-4ph9A:63.5","4m11B-4ph9A:99.64"],["4M11_C_MXMC606_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",8,"MET A 114;ILE A 346;VAL A 350;LEU A 360;TRP A 388;VAL A 524;ALA A 528;LEU A 535","None;None;IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A);EDO A 616 ( 4.4A)","0.36A","4m11C-4ph9A:63.5","4m11B-4ph9A:99.64"],["4M11_C_MXMC606_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",7,"MET A 114;VAL A 117;ILE A 346;VAL A 350;LEU A 360;TRP A 388;LEU A 535","None;BOG A 604 (-3.9A);None;IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;EDO A 616 ( 4.4A)","0.57A","4m11C-4ph9A:63.5","4m11C-4ph9A:99.64"],["4M11_C_MXMC606_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",5,"MET A 114;VAL A 117;VAL A 350;LEU A 360;SER A 531","None;BOG A 604 (-3.9A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 ( 3.3A)","0.84A","4m11C-4ph9A:63.5","4m11C-4ph9A:99.64"],["4M11_C_MXMC606_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",6,"MET A 114;VAL A 350;LEU A 360;VAL A 524;ALA A 528;SER A 531","None;IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 ( 4.0A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","0.69A","4m11C-4ph9A:63.5","4m11C-4ph9A:99.64"],["4M11_D_MXMD606_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",5,"MET A 114;LEU A 353;TRP A 388;VAL A 524;ALA A 528","None;IBP A 601 ( 4.7A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A)","0.74A","4m11D-4ph9A:63.6","4m11C-4ph9A:99.64"],["4M11_D_MXMD606_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"MET A 114;VAL A 117;ARG A 121;ILE A 346;VAL A 350;LEU A 360;TRP A 388;VAL A 524;ALA A 528","None;BOG A 604 (-3.9A);BOG A 604 ( 3.7A);None;IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A)","0.54A","4m11D-4ph9A:63.6","4m11D-4ph9A:99.64"],["4M11_D_MXMD606_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",7,"MET A 114;VAL A 117;ARG A 121;VAL A 350;LEU A 360;ALA A 528;SER A 531","None;BOG A 604 (-3.9A);BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","0.78A","4m11D-4ph9A:63.6","4m11D-4ph9A:99.64"],["4O1Z_A_MXMA807_2","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",5,"VAL A 117;LEU A 118;ARG A 121;LEU A 360;MET A 523","BOG A 604 (-3.9A);None;BOG A 604 ( 3.7A);IBP A 601 ( 4.7A);None","0.64A","4o1zA-4ph9A:58.8","4m11D-4ph9A:99.64"],["4O1Z_A_MXMA807_2","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",5,"VAL A 117;LEU A 118;LEU A 360;PHE A 519;MET A 523","BOG A 604 (-3.9A);None;IBP A 601 ( 4.7A);None;None","0.77A","4o1zA-4ph9A:58.8","4o1zA-4ph9A:64.31"],["4O1Z_B_MXMB807_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"MET A 114;VAL A 117;LEU A 118;ARG A 121;ILE A 346;VAL A 350;LEU A 360;TRP A 388;PHE A 519;ALA A 528;SER A 531","None;BOG A 604 (-3.9A);None;BOG A 604 ( 3.7A);None;IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;None;IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","0.77A","4o1zB-4ph9A:58.8","4o1zA-4ph9A:64.31"],["4O1Z_B_MXMB807_1","PROSTAGLANDIN G\/H SYNTHASE 1","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"MET A 114;VAL A 117;LEU A 118;ARG A 121;TRP A 388;PHE A 519;ALA A 528;SER A 531;LEU A 532","None;BOG A 604 (-3.9A);None;BOG A 604 ( 3.7A);None;None;IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","1.07A","4o1zB-4ph9A:58.8","4o1zB-4ph9A:64.31"],["4OTY_A_LURA705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",6,"LEU A 353;SER A 354;TYR A 356;LEU A 508;TRP A 388;VAL A 524","IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);None;None;IBP A 601 ( 4.0A)","1.49A","4otyA-4ph9A:63.6","4o1zB-4ph9A:64.31"],["4OTY_A_LURA705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",6,"SER A 354;TYR A 356;LEU A 526;ALA A 528;SER A 531;LEU A 532","None;IBP A 601 (-4.5A);None;IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","1.11A","4otyA-4ph9A:63.6","4otyA-4ph9A:99.64"],["4OTY_A_LURA705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",6,"SER A 354;TYR A 356;LEU A 526;GLY A 527;ALA A 528;LEU A 532","None;IBP A 601 (-4.5A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","1.36A","4otyA-4ph9A:63.6","4otyA-4ph9A:99.64"],["4OTY_A_LURA705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 350;LEU A 353;SER A 354;TYR A 356;LEU A 385;TRP A 388;VAL A 524;GLY A 527;ALA A 528;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.59A","4otyA-4ph9A:63.6","4otyA-4ph9A:99.64"],["4OTY_A_LURA705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.63A","4otyA-4ph9A:63.6","4otyA-4ph9A:99.64"],["4OTY_A_LURA705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.37A","4otyA-4ph9A:63.6","4otyA-4ph9A:99.64"],["4OTY_B_LURB705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",7,"SER A 354;TYR A 356;LEU A 526;VAL A 524;ALA A 528;SER A 531;LEU A 532","None;IBP A 601 (-4.5A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","1.27A","4otyB-4ph9A:63.6","4otyA-4ph9A:99.64"],["4OTY_B_LURB705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",7,"SER A 354;TYR A 356;LEU A 526;VAL A 524;GLY A 527;ALA A 528;LEU A 532","None;IBP A 601 (-4.5A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","1.37A","4otyB-4ph9A:63.6","4otyB-4ph9A:99.64"],["4OTY_B_LURB705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 350;LEU A 353;SER A 354;TYR A 356;LEU A 385;TRP A 388;VAL A 524;GLY A 527;ALA A 528;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.56A","4otyB-4ph9A:63.6","4otyB-4ph9A:99.64"],["4OTY_B_LURB705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.58A","4otyB-4ph9A:63.6","4otyB-4ph9A:99.64"],["4OTY_B_LURB705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.33A","4otyB-4ph9A:63.6","4otyB-4ph9A:99.64"],["4P6X_G_HCYG900_1","GLUCOCORTICOID RECEPTOR","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",5,"ASN A 196;GLY A 194;GLN A 193;LEU A 353;THR A 579","None;None;None;IBP A 601 ( 4.7A);None","1.48A","4p6xG-4ph9A:undetectable","4otyB-4ph9A:99.64"],["4P6X_I_HCYI900_1","GLUCOCORTICOID RECEPTOR","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",5,"ASN A 196;GLY A 194;GLN A 193;LEU A 353;THR A 579","None;None;None;IBP A 601 ( 4.7A);None","1.45A","4p6xI-4ph9A:undetectable","4p6xG-4ph9A:19.82"],["4RRW_A_LURA705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;MET A 523;VAL A 524;GLY A 527;ALA A 528;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.56A","4rrwA-4ph9A:63.7","4p6xI-4ph9A:19.82"],["4RRW_A_LURA705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.73A","4rrwA-4ph9A:63.7","4rrwA-4ph9A:99.46"],["4RRW_B_LURB705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;MET A 523;VAL A 524;GLY A 527;ALA A 528;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.55A","4rrwB-4ph9A:63.8","4rrwA-4ph9A:99.46"],["4RRW_B_LURB705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.74A","4rrwB-4ph9A:63.8","4rrwB-4ph9A:99.46"],["4RRW_C_LURC705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"VAL A 350;LEU A 353;SER A 354;TYR A 356;LEU A 385;VAL A 524;GLY A 527;ALA A 528;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.77A","4rrwC-4ph9A:63.7","4rrwB-4ph9A:99.46"],["4RRW_C_LURC705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.72A","4rrwC-4ph9A:63.7","4rrwC-4ph9A:99.46"],["4RRW_C_LURC705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"VAL A 350;SER A 354;TYR A 356;LEU A 526;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","1.32A","4rrwC-4ph9A:63.7","4rrwC-4ph9A:99.46"],["4RRW_D_LURD705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",8,"LEU A 353;SER A 354;TYR A 356;LEU A 385;VAL A 524;GLY A 527;ALA A 528;LEU A 532","IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.65A","4rrwD-4ph9A:63.8","4rrwC-4ph9A:99.46"],["4RRW_D_LURD705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.59A","4rrwD-4ph9A:63.8","4rrwD-4ph9A:99.46"],["4RRW_D_LURD705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.36A","4rrwD-4ph9A:63.8","4rrwD-4ph9A:99.46"],["4RRW_D_LURD705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",8,"VAL A 350;SER A 354;TYR A 356;LEU A 526;VAL A 524;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","1.22A","4rrwD-4ph9A:63.8","4rrwD-4ph9A:99.46"],["4RRW_D_LURD705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",8,"VAL A 350;SER A 354;TYR A 356;LEU A 526;VAL A 524;GLY A 527;ALA A 528;LEU A 532","IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","1.30A","4rrwD-4ph9A:63.8","4rrwD-4ph9A:99.46"],["4RRX_A_LURA706_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"TYR A 349;VAL A 350;LEU A 353;TYR A 356;LEU A 385;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;LEU A 532","None;IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);None;IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.58A","4rrxA-4ph9A:63.2","4rrwD-4ph9A:99.46"],["4RRX_A_LURA706_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"TYR A 349;VAL A 350;LEU A 353;TYR A 356;TYR A 386;TRP A 388;VAL A 524;ALA A 528;SER A 531;LEU A 532","None;IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.72A","4rrxA-4ph9A:63.2","4rrxA-4ph9A:99.46"],["4RRX_B_LURB706_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"TYR A 349;VAL A 350;LEU A 353;TYR A 356;LEU A 385;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;LEU A 532","None;IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);None;IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.62A","4rrxB-4ph9A:37.1","4rrxA-4ph9A:99.46"],["4RRX_B_LURB706_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"TYR A 349;VAL A 350;LEU A 353;TYR A 356;TYR A 386;TRP A 388;VAL A 524;ALA A 528;SER A 531;LEU A 532","None;IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.73A","4rrxB-4ph9A:37.1","4rrxB-4ph9A:99.46"],["4RRZ_A_LURA705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;MET A 523;VAL A 524;GLY A 527;ALA A 528;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.56A","4rrzA-4ph9A:63.7","4rrxB-4ph9A:99.46"],["4RRZ_A_LURA705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.73A","4rrzA-4ph9A:63.7","4rrzA-4ph9A:99.46"],["4RRZ_B_LURB705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;MET A 523;VAL A 524;GLY A 527;ALA A 528;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.55A","4rrzB-4ph9A:63.8","4rrzA-4ph9A:99.46"],["4RRZ_B_LURB705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.74A","4rrzB-4ph9A:63.8","4rrzB-4ph9A:99.46"],["4RRZ_C_LURC705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"VAL A 350;LEU A 353;SER A 354;TYR A 356;LEU A 385;VAL A 524;GLY A 527;ALA A 528;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.77A","4rrzC-4ph9A:63.7","4rrzB-4ph9A:99.46"],["4RRZ_C_LURC705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.72A","4rrzC-4ph9A:63.7","4rrzC-4ph9A:99.46"],["4RRZ_C_LURC705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"VAL A 350;SER A 354;TYR A 356;LEU A 526;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","1.32A","4rrzC-4ph9A:63.7","4rrzC-4ph9A:99.46"],["4RRZ_D_LURD705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",8,"LEU A 353;SER A 354;TYR A 356;LEU A 385;VAL A 524;GLY A 527;ALA A 528;LEU A 532","IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.65A","4rrzD-4ph9A:63.8","4rrzC-4ph9A:99.46"],["4RRZ_D_LURD705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.59A","4rrzD-4ph9A:63.8","4rrzD-4ph9A:99.46"],["4RRZ_D_LURD705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.36A","4rrzD-4ph9A:63.8","4rrzD-4ph9A:99.46"],["4RRZ_D_LURD705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",8,"VAL A 350;SER A 354;TYR A 356;LEU A 526;VAL A 524;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","1.22A","4rrzD-4ph9A:63.8","4rrzD-4ph9A:99.46"],["4RRZ_D_LURD705_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",8,"VAL A 350;SER A 354;TYR A 356;LEU A 526;VAL A 524;GLY A 527;ALA A 528;LEU A 532","IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","1.30A","4rrzD-4ph9A:63.8","4rrzD-4ph9A:99.46"],["4RS0_A_IBPA706_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",9,"ARG A 121;VAL A 350;LEU A 353;SER A 354;TYR A 356;LEU A 360;GLY A 527;ALA A 528;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.22A","4rs0A-4ph9A:63.0","4rrzD-4ph9A:99.46"],["5F1A_A_SALA601_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",5,"LEU A 353;LEU A 385;TYR A 386;TRP A 388;GLY A 527","IBP A 601 ( 4.7A);None;IBP A 601 (-4.8A);None;IBP A 601 (-3.9A)","0.69A","5f1aA-4ph9A:63.4","4rs0A-4ph9A:99.46"],["5F1A_A_SALA601_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",6,"VAL A 350;LEU A 385;TYR A 386;TRP A 388;GLY A 527;ALA A 528","IBP A 601 (-4.3A);None;IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A)","0.20A","5f1aA-4ph9A:63.4","5f1aA-4ph9A:88.02"],["5F1A_A_SALA601_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",4,"VAL A 350;TYR A 386;ALA A 528;SER A 531","IBP A 601 (-4.3A);IBP A 601 (-4.8A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","0.74A","5f1aA-4ph9A:63.4","5f1aA-4ph9A:88.02"],["5F1A_B_SALB601_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",6,"VAL A 350;LEU A 385;TYR A 386;TRP A 388;GLY A 527;ALA A 528","IBP A 601 (-4.3A);None;IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A)","0.17A","5f1aB-4ph9A:63.4","5f1aA-4ph9A:88.02"],["5F1A_B_SALB601_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",5,"VAL A 350;TYR A 386;TRP A 388;ALA A 528;SER A 531","IBP A 601 (-4.3A);IBP A 601 (-4.8A);None;IBP A 601 (-3.4A);IBP A 601 ( 3.3A)","0.64A","5f1aB-4ph9A:63.4","5f1aB-4ph9A:88.02"],["5F9Z_A_HFGA702_0","AMINOACYL-TRNA SYNTHETASE","2wd9","ACYL-COENZYME A SYNTHETASE ACSM2A, MITOCHONDRIAL","Homo sapiens",5,"LEU A 267;GLY A 470;GLU A 339;VAL A 337;PHE A 291","IBP A1570 (-3.7A);None;None;IBP A1570 (-4.6A);None","1.27A","5f9zA-2wd9A:undetectable","5f1aB-4ph9A:88.02"],["5IKQ_A_JMSA602_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 385;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);None;IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.36A","5ikqA-4ph9A:62.7","5f9zA-2wd9A:23.52"],["5IKQ_A_JMSA602_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"ARG A 121;VAL A 350;LEU A 353;TYR A 356;TYR A 386;TRP A 388;VAL A 524;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.61A","5ikqA-4ph9A:62.7","5ikqA-4ph9A:88.02"],["5IKQ_B_JMSB602_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 385;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);None;IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.32A","5ikqB-4ph9A:62.9","5ikqA-4ph9A:88.02"],["5IKQ_B_JMSB602_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"ARG A 121;VAL A 350;LEU A 353;TYR A 356;TYR A 386;TRP A 388;VAL A 524;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.61A","5ikqB-4ph9A:62.9","5ikqB-4ph9A:88.02"],["5IKR_A_ID8A601_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"ARG A 121;VAL A 350;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.61A","5ikrA-4ph9A:63.0","5ikqB-4ph9A:88.02"],["5IKR_A_ID8A601_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"ARG A 121;VAL A 350;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.33A","5ikrA-4ph9A:63.0","5ikrA-4ph9A:88.02"],["5IKR_A_ID8A601_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;ALA A 528;SER A 531;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.72A","5ikrA-4ph9A:63.0","5ikrA-4ph9A:88.02"],["5IKR_A_ID8A601_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 350;LEU A 353;SER A 354;TYR A 356;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;LEU A 532","IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.50A","5ikrA-4ph9A:63.0","5ikrA-4ph9A:88.02"],["5IKR_B_ID8B602_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;VAL A 524;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.66A","5ikrB-4ph9A:62.8","5ikrA-4ph9A:88.02"],["5IKR_B_ID8B602_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.44A","5ikrB-4ph9A:62.8","5ikrB-4ph9A:88.02"],["5IKT_A_TLFA601_0","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"VAL A 117;ARG A 121;VAL A 350;SER A 354;TYR A 356;LEU A 385;TRP A 388;MET A 523;VAL A 524;GLY A 527;ALA A 528;LEU A 532","BOG A 604 (-3.9A);BOG A 604 ( 3.7A);IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);None;None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.49A","5iktA-4ph9A:63.1","5ikrB-4ph9A:88.02"],["5IKT_B_TLFB601_0","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",10,"VAL A 117;ARG A 121;VAL A 350;LEU A 385;TRP A 388;MET A 523;VAL A 524;GLY A 527;ALA A 528;LEU A 532","BOG A 604 (-3.9A);BOG A 604 ( 3.7A);IBP A 601 (-4.3A);None;None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.39A","5iktB-4ph9A:63.1","5iktA-4ph9A:88.02"],["5IKT_B_TLFB601_0","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"VAL A 117;VAL A 350;LEU A 353;SER A 354;LEU A 385;TRP A 388;MET A 523;VAL A 524;GLY A 527;ALA A 528;LEU A 532","BOG A 604 (-3.9A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);None;None;None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.33A","5iktB-4ph9A:63.1","5iktB-4ph9A:88.02"],["5IKT_B_TLFB601_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",3,"TYR A 356;TYR A 386;SER A 531","IBP A 601 (-4.5A);IBP A 601 (-4.8A);IBP A 601 ( 3.3A)","0.83A","5iktB-4ph9A:63.1","5iktB-4ph9A:88.02"],["5JVZ_A_FLPA601_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"ARG A 121;VAL A 350;LEU A 353;TYR A 356;LEU A 360;TYR A 386;TRP A 388;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.47A","5jvzA-4ph9A:64.0","5iktB-4ph9A:88.02"],["5JVZ_B_FLPB601_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"ARG A 121;LEU A 353;SER A 354;TYR A 356;LEU A 360;TYR A 386;TRP A 388;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 ( 4.7A);None;IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.55A","5jvzB-4ph9A:64.0","5jvzA-4ph9A:99.82"],["5JVZ_B_FLPB601_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"ARG A 121;VAL A 350;SER A 354;TYR A 356;LEU A 360;TYR A 386;TRP A 388;GLY A 527;ALA A 528;SER A 531;LEU A 532","BOG A 604 ( 3.7A);IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);IBP A 601 ( 4.7A);IBP A 601 (-4.8A);None;IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.23A","5jvzB-4ph9A:64.0","5jvzB-4ph9A:99.82"],["5JW1_A_CELA602_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"HIS A  90;GLN A 193;VAL A 350;TYR A 356;LEU A 360;TRP A 388;ALA A 517;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","None;None;IBP A 601 (-4.3A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.42A","5jw1A-4ph9A:62.6","5jvzB-4ph9A:99.82"],["5JW1_A_CELA602_2","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",6,"VAL A 117;LEU A 353;SER A 354;ARG A 514;ILE A 518;PHE A 519","BOG A 604 (-3.9A);IBP A 601 ( 4.7A);None;None;None;None","0.47A","5jw1A-4ph9A:62.6","5jw1A-4ph9A:99.82"],["5JW1_B_CELB602_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"HIS A  90;ARG A 121;GLN A 193;LEU A 353;TYR A 356;LEU A 360;TRP A 388;ALA A 517;VAL A 524;GLY A 527;ALA A 528","None;BOG A 604 ( 3.7A);None;IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A)","0.76A","5jw1B-4ph9A:62.7","5jw1A-4ph9A:99.82"],["5JW1_B_CELB602_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",11,"HIS A  90;GLN A 193;LEU A 353;TYR A 356;LEU A 360;TRP A 388;ALA A 517;VAL A 524;GLY A 527;ALA A 528;LEU A 532","None;None;IBP A 601 ( 4.7A);IBP A 601 (-4.5A);IBP A 601 ( 4.7A);None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 4.9A)","0.35A","5jw1B-4ph9A:62.7","5jw1B-4ph9A:99.82"],["5JW1_B_CELB602_2","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",6,"VAL A 117;VAL A 350;SER A 354;ARG A 514;ILE A 518;PHE A 519","BOG A 604 (-3.9A);IBP A 601 (-4.3A);None;None;None;None","0.30A","5jw1B-4ph9A:62.7","5jw1B-4ph9A:99.82"],["5KIR_A_RCXA601_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"HIS A  90;GLN A 193;VAL A 350;LEU A 353;TYR A 356;TRP A 388;ALA A 517;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","None;None;IBP A 601 (-4.3A);IBP A 601 ( 4.7A);IBP A 601 (-4.5A);None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.25A","5kirA-4ph9A:62.4","5jw1B-4ph9A:99.82"],["5KIR_B_RCXB601_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",6,"ALA A 436;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","1.43A","5kirB-4ph9A:63.0","5kirA-4ph9A:87.84"],["5KIR_B_RCXB601_1","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",12,"HIS A  90;GLN A 193;VAL A 350;SER A 354;TYR A 356;TRP A 388;ALA A 517;VAL A 524;GLY A 527;ALA A 528;SER A 531;LEU A 532","None;None;IBP A 601 (-4.3A);None;IBP A 601 (-4.5A);None;None;IBP A 601 ( 4.0A);IBP A 601 (-3.9A);IBP A 601 (-3.4A);IBP A 601 ( 3.3A);IBP A 601 ( 4.9A)","0.32A","5kirB-4ph9A:63.0","5kirB-4ph9A:87.84"],["5KIR_B_RCXB601_2","PROSTAGLANDIN G\/H SYNTHASE 2","4ph9","PROSTAGLANDIN G\/H SYNTHASE 2","Mus musculus",4,"LEU A 353;ARG A 514;ILE A 518;PHE A 519","IBP A 601 ( 4.7A);None;None;None","0.34A","5kirB-4ph9A:63.0","5kirB-4ph9A:87.84"],["5NWV_A_ACAA18_1","SCRFP-TAG,GP41","2wd9","ACYL-COENZYME A SYNTHETASE ACSM2A, MITOCHONDRIAL","Homo sapiens",5,"LEU A 251;GLY A 247;GLU A 275;LEU A 270;LEU A 368","None;None;None;None;IBP A1570 ( 4.4A)","1.17A","5nwvA-2wd9A:undetectable","5kirB-4ph9A:87.84"]]